{
    "2021-04-08": [
        [
            {
                "time": "",
                "original_text": "海南自贸港迎重磅利好，国产新冠疫苗明年产能将达50亿剂丨明日主题前瞻",
                "features": {
                    "keywords": [
                        "海南自贸港",
                        "新冠疫苗",
                        "产能",
                        "50亿剂"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国内疫苗接种提速，明年产能将达50亿剂，行业或迎放量密集期",
                "features": {
                    "keywords": [
                        "疫苗接种",
                        "提速",
                        "产能",
                        "放量密集期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年一季度疫苗行业批签发专题报告：大品种批签发快速增长 行业高景气度持续",
                "features": {
                    "keywords": [
                        "医药行业",
                        "批签发",
                        "大品种",
                        "高景气度"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗股整体强势，辽宁成大、康泰生物、万泰生物均涨超5%",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "辽宁成大",
                        "康泰生物",
                        "万泰生物",
                        "涨超5%"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股异动 | 康泰生物(300601.SZ)涨近5% P3生物安全生产车间已完成建设并通过国家生物安全认证",
                "features": {
                    "keywords": [
                        "A股",
                        "康泰生物",
                        "P3生物安全",
                        "生产车间",
                        "国家生物安全认证"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医疗体系运行常态化 看好一季度业绩表现",
                "features": {
                    "keywords": [
                        "医药生物行业",
                        "医疗体系",
                        "常态化",
                        "一季度业绩"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}